Patient Questionnaires in Rheumatoid Arthritis: Advantages and Limitations as a Quantitative, Standardized Scientific Medical History

Rheumatic Disease Clinics of North America

Volumn 35, Issue 4, 2009, Pages 735-743

  Pincus, Theodore ^a   Yazici, Yusuf ^a   Bergman, Martin J ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Taylor Hospital   (United States)

Author keywords

HAQ (health assessment questionnaire); MDHAQ (multidimensional health assessment questionnaire); Patient self report questionnaires; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; C REACTIVE PROTEIN; LEFLUNOMIDE; METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ACCURACY; ANAMNESIS; CLINICAL TRIAL; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FUNCTIONAL ASSESSMENT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT DESTRUCTION; JOINT SWELLING; PAIN ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RELIABILITY; REVIEW; RHEUMATOID ARTHRITIS; SELF REPORT; SHORT FORM 36; VISUAL ANALOG SCALE; WORK DISABILITY;

ARTHRITIS, RHEUMATOID; HEALTH STATUS; HUMANS; MEDICAL HISTORY TAKING; QUESTIONNAIRES;

EID: 70749083027     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2009.10.009     Document Type: Review

References (52)

1. Pincus T., Yazici Y., and Sokka T. Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages, and limitations. Best Pract Res Clin Rheumatol 21 (2007) 601-628
2. Pincus T., Callahan L.F., Brooks R.H., et al. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. Ann Intern Med 110 (1989) 259-266
3. Strand V., Cohen S., Crawford B., et al. Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis. Rheumatology 43 (2004) 640-647
4. Cohen S.B., Strand V., Aguilar D., et al. Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy. Rheumatology 43 (2004) 704-711
5. Pincus T., Amara I., Segurado O.G., et al. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials. J Rheumatol 35 (2008) 201-205
6. Wells G., Li T., Maxwell L., et al. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis 67 (2008) 260-265
7. Pincus T., Bergman M.J., Yazici Y., et al. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology (Oxford) 47 (2008) 345-349
8. Wolfe F., Michaud K., and Pincus T. A composite disease activity scale for clinical practice, observational studies and clinical trials: the patient activity scale (PAS/PAS-II). J Rheumatol 32 (2005) 2410-2415
9. Pincus T., Swearingen C.J., Bergman M., et al. RAPID3 (routine assessment of patient index data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to DAS and CDAI categories. J Rheumatol 35 (2008) 2136-2147
10. Pincus T., Callahan L.F., Sale W.G., et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27 (1984) 864-872
11. Wolfe F., and Cathey M.A. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 18 (1991) 1298-1306
12. Callahan L.F., Bloch D.A., and Pincus T. Identification of work disability in rheumatoid arthritis: Physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol 45 (1992) 127-138
13. Wolfe F., and Hawley D.J. The long-term outcomes of rheumatoid arthritis: work disability: a prospective 18-year study of 823 patients. J Rheumatol 25 (1998) 2108-2117
14. Sokka T., Kautiainen H., Möttönen T., et al. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 26 (1999) 1681-1685
15. Lubeck D.P., Spitz P.W., Fries J.F., et al. A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum 29 (1986) 488-493
16. Wolfe F., and Zwillich S.H. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1600 patients with rheumatoid arthritis. Arthritis Rheum 41 (1998) 1072-1082
17. Wolfe F., Kleinheksel S.M., Cathey M.A., et al. The clinical value of the Stanford health assessment questionnaire functional disability Index in patients with rheumatoid arthritis. J Rheumatol 15 (1988) 1480-1488
18. Leigh J.P., and Fries J.F. Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol 18 (1991) 1307-1312
19. Pincus T., Brooks R.H., and Callahan L.F. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 120 (1994) 26-34
20. Callahan L.F., Cordray D.S., Wells G., et al. Formal education and five-year mortality in rheumatoid arthritis: mediation by helplessness scale scores. Arthritis Care Res 9 (1996) 463-472
21. Callahan L.F., Pincus T., Huston III J.W., et al. Measures of activity and damage in rheumatoid arthritis: Depiction of changes and prediction of mortality over five years. Arthritis Care Res 10 (1997) 381-394
22. Söderlin M.K., Nieminen P., and Hakala M. Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol 25 (1998) 1895-1899
23. Sokka T., Hakkinen A., Krishnan E., et al. Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population. Ann Rheum Dis 63 (2004) 494-497
24. Sokka T., Abelson B., and Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 26 (2008) S35-S61
25. Pincus T., and Wolfe F. An infrastructure of patient questionnaires at each rheumatology visit: improving efficiency and documenting care. J Rheumatol 27 (2000) 2727-2730
26. Pincus T., Yazici Y., and Bergman M. Development of a multidimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical care. Clin Exp Rheumatol 23 (2005) S19-S28
27. Fries J.F., Spitz P., Kraines R.G., et al. Measurement of patient outcome in arthritis. Arthritis Rheum 23 (1980) 137-145
28. Pincus T., Summey J.A., Soraci Jr. S.A., et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum 26 (1983) 1346-1353
29. Wolfe F., Michaud K., and Pincus T. Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis Rheum 50 (2004) 3296-3305
30. Pincus T., Swearingen C., and Wolfe F. Toward a multidimensional health assessment questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient friendly health assessment questionnaire format. Arthritis Rheum 42 (1999) 2220-2230
31. Pincus T., Sokka T., and Kautiainen H. Further development of a physical function scale on a multidimensional health assessment questionnaire for standard care of patients with rheumatic diseases. J Rheumatol 32 (2005) 1432-1439
32. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30 (1992) 473-481
33. Ware Jr. J., Kosinski M., and Keller S.D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220-233
34. Fries J.F., and Ramey D.R. Arthritis-specific global health analog scales assess generic health-related quality-of-life in patients with rheumatoid arthritis. J Rheumatol 24 (1997) 1697-1702
35. van der Heijde D.M., van't Hof M., van Riel P.L., et al. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20 (1993) 579-581
36. Hurst N.P., Jobanputra P., Hunter M., et al. Validity of Euroqol-a generic health status instrument-in patients with rheumatoid arthritis. Br J Rheumatol 33 (1994) 655-662
37. Melzack R. The short-form McGill Pain Questionnaire. Pain 30 (1987) 191-197
38. Krupp L.B., LaRocca N.G., Muir-Nash J., et al. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 (1989) 1121-1123
39. Tugwell P., Bombardier C., Buchanan W.W., et al. The MACTAR patient preference disability questionnaire - an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 14 (1987) 446-451
40. Clinch J., Tugwell P., Wells G., et al. Individualized functional priority approach to the assessment of health related quality of life in rheumatology. J Rheumatol 28 (2001) 445-451
41. Bellamy N., Buchanan W.W., Goldsmith C.H., et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15 (1988) 1833-1840
42. Burckhardt C.S., Clark S.R., and Bennett R.M. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18 (1991) 728-733
43. Fries J.F., Bruce B., and Cella D. The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol 23 (2005) S53-S57
44. Hewlett S., Kirwan J., Pollock J., et al. Patient initiated outpatient follow up in rheumatoid arthritis: six-year randomised controlled trial. Br Med J 330 (2005) 171-174
45. Pincus T., Gibofsky A., and Weinblatt M.E. Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum 46 (2002) 851-854
46. Wolfe F., Pincus T., Thompson A.K., et al. The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice. Arthritis Care Res 49 (2003) 59-63
47. Russak S.M., Croft J.D., Furst D.E., et al. The use of rheumatoid arthritis health-related quality of life patient questionnaires in clinical practice: lessons learned. Arthritis Care Res 49 (2003) 574-584
48. Aletaha D., Smolen J., and Ward M.M. Measuring function in rheumatoid arthritis: identifying reversible and irreversible components. Arthritis Rheum 54 (2006) 2784-2792
49. Yazici Y., Kautiainen H., and Sokka T. Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data. J Rheumatol 34 (2007) 311-315
50. Pincus T., and Callahan L.F. Rheumatology function tests: grip strength, walking time, button test and questionnaires document and predict long-term morbidity and mortality in rheumatoid arthritis. J Rheumatol 19 (1992) 1051-1057
51. Pincus T. Rheumatology function tests: quantitative physical measures to monitor morbidity and predict mortality in patients with rheumatic diseases. Clin Exp Rheumatol 23 (2005) S85-S89
52. Pincus T., Brooks R.H., and Callahan L.F. Reliability of grip strength, walking time and button test performed according to a standard protocol. J Rheumatol 18 (1991) 997-1000